GSK2018682 is an agonist of sphingosine-1-phosphate receptor 1 (S1P1) and S1P5.1 It is selective for S1P1 and S1P5 over S1P2, S1P3, and S1P4 receptors. GSK2018682 is efficacious in a mouse model of experimental autoimmune encephalomyelitis (EAE).
1.Xu, J., Gray, F., Henderson, A., et al.Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteersClin. Pharmacol. Drug Dev.3(3)170-178(2014)
















